聯合健康集團UNH
紐約證券 · USD
266.04
+4.97
(+1.90%)
收盤 07/31 03:59 (UTC+8)
盤後
264.95
264.95
(-0.41%)
07/31 03:59 (UTC+8)
聯合健康集團UNH
266.04
+4.97
(+1.90%)
財務數據
損益表
- 827.87
- 919.31
- 929.03
- 923.61
- 944.27
- 997.96
- 988.55
- 1008.20
- 1008.07
- 1095.75
- 2.34
- 11.05
- 1.06
- -0.58
- 2.24
- 5.69
- -0.94
- 1.99
- -0.01
- 8.70
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 109,575,000 | 100,807,000 | 100,820,000 | 98,855,000 | 99,796,000 | 94,427,000 | 92,361,000 | 92,903,000 | 91,931,000 | 82,787,000 |
營業成本 | 73,411,000 | 67,035,000 | 65,957,000 | 65,458,000 | 65,735,000 | 62,231,000 | 59,550,000 | 60,268,000 | 59,845,000 | 53,591,000 |
營業毛利 | 36,164,000 | 33,772,000 | 34,863,000 | 33,397,000 | 34,061,000 | 32,196,000 | 32,811,000 | 32,635,000 | 32,086,000 | 29,196,000 |
營業費用 | 27,045,000 | - | - | - | 26,130,000 | 24,507,000 | 24,285,000 | 24,578,000 | 24,000,000 | 22,305,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | - | - | - | - | - | - | - | - | - | - |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 27,045,000 | 25,999,000 | 26,155,000 | 25,522,000 | 26,130,000 | 24,507,000 | 24,285,000 | 24,578,000 | 24,000,000 | 22,305,000 |
營業利益 | 9,119,000 | 7,773,000 | 8,708,000 | 7,875,000 | 7,931,000 | 7,689,000 | 8,526,000 | 8,057,000 | 8,086,000 | 6,891,000 |
其他收入及費用 | -15,000 | 21,000 | -20,000 | -1,225,000 | -7,086,000 | - | - | - | - | - |
利息費用 | 998,000 | 1,003,000 | 1,074,000 | 985,000 | 844,000 | 830,000 | 834,000 | 828,000 | 754,000 | 676,000 |
稅前純益 | 8,106,000 | 6,791,000 | 7,614,000 | 5,665,000 | 1,000 | 6,859,000 | 7,692,000 | 7,229,000 | 7,332,000 | 6,215,000 |
所得稅 | 1,632,000 | 1,007,000 | 1,356,000 | 1,244,000 | 1,222,000 | 1,184,000 | 1,654,000 | 1,572,000 | 1,558,000 | 1,307,000 |
稅後純益 | 6,292,000 | 5,543,000 | 6,055,000 | 4,216,000 | -1,409,000 | 5,455,000 | 5,841,000 | 5,474,000 | 5,611,000 | 4,761,000 |
基本每股稅後盈餘(元) | 6.91 | 6.06 | 6.51 | 4.58 | -1.53 | 5.90 | 6.31 | 5.89 | 6.01 | 5.10 |
稀釋每股稅後盈餘(元) | 6.85 | 5.98 | 6.51 | 4.55 | -1.53 | 5.85 | 6.24 | 5.82 | 5.95 | 5.03 |
基本平均股數(千股) | 910000.00 | 915000.00 | 930107.00 | 921000.00 | 920000.00 | 924000.00 | 926000.00 | 930000.00 | 933000.00 | 934000.00 |
稀釋平均股數(千股) | 918000.00 | 927000.00 | 930107.00 | 928000.00 | 922000.00 | 935000.00 | 936000.00 | 940000.00 | 943000.00 | 947000.00 |
還原基本每股稅後盈餘(元) | 6.91 | 6.06 | 6.51 | 4.58 | -1.53 | 5.90 | 6.31 | 5.89 | 6.01 | 5.10 |
還原稀釋每股稅後盈餘(元) | 6.85 | 5.98 | 6.51 | 4.55 | -1.53 | 5.85 | 6.24 | 5.82 | 5.95 | 5.03 |
還原基本平均股數(千股) | 910,000 | 915,000 | 930,107 | 921,000 | 920,000 | 924,000 | 926,000 | 930,000 | 933,000 | 934,000 |
還原稀釋平均股數(千股) | 918,000 | 927,000 | 930,107 | 928,000 | 922,000 | 935,000 | 936,000 | 940,000 | 943,000 | 947,000 |
EBITDA(千元) | 9,983,000 | 8,594,000 | 9,526,000 | 7,465,000 | 1,654,000 | 8,443,000 | 9,336,000 | 8,895,000 | 8,893,000 | 7,726,000 |